| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11014204 | Joint Bone Spine | 2018 | 7 Pages |
Abstract
Retention rate was lower after switching from OI to CT-P13 compared to our control cohorts. However, this difference faded after excluding patients without objective clinical activity, suggesting a reluctance of patients to the switch and a negative perception of the biosimilar.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Marc Scherlinger, Vincent Germain, Céline Labadie, Thomas Barnetche, Marie-Elise Truchetet, Bernard Bannwarth, Nadia Mehsen-Cetre, Christophe Richez, Thierry Schaeverbeke, FHU ACRONIM FHU ACRONIM,